These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons. Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602 [TBL] [Abstract][Full Text] [Related]
8. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease. Park HJ; Han A; Kim JY; Choi J; Bae HS; Cho GB; Shin H; Shin EJ; Lee KI; Kim S; Lee JY; Song J NPJ Regen Med; 2022 Jan; 7(1):8. PubMed ID: 35046408 [TBL] [Abstract][Full Text] [Related]
10. Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases. Dabrowska M; Juzwa W; Krzyzosiak WJ; Olejniczak M Front Neurosci; 2018; 12():75. PubMed ID: 29535594 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells. Zhang N; An MC; Montoro D; Ellerby LM PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797 [TBL] [Abstract][Full Text] [Related]
14. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease. Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816 [TBL] [Abstract][Full Text] [Related]
15. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells. Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411 [TBL] [Abstract][Full Text] [Related]
16. Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines. Niclis JC; Pinar A; Haynes JM; Alsanie W; Jenny R; Dottori M; Cram DS Front Cell Neurosci; 2013; 7():37. PubMed ID: 23576953 [TBL] [Abstract][Full Text] [Related]
17. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. Lu B; Palacino J FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320 [TBL] [Abstract][Full Text] [Related]
18. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells. Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787 [TBL] [Abstract][Full Text] [Related]
19. iPSC-based drug screening for Huntington's disease. Zhang N; Bailus BJ; Ring KL; Ellerby LM Brain Res; 2016 May; 1638(Pt A):42-56. PubMed ID: 26428226 [TBL] [Abstract][Full Text] [Related]